Markel CEO May Be Absent for Two Months for Treatment
Kirshner should return to work in February, he said today in a statement distributed by PR Newswire. The statement didn’t give details on Kirshner’s medical treatment.
“For the next 60 days he’s going to be dealing with a procedure that will render him less accessible than he would otherwise be,” Bruce Kay, a spokesman for Markel, said in a telephone interview today. “It’s not emergency surgery.”
To contact the editor responsible for this story: Dan Kraut in New York at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.